Research & Development
Alira Health Secures an Additional $40M in Funding, Led by Creadev
We announced today the closing of an equity financing in which it raised gross proceeds of US$40 million. We intend to use the funds to invest in solutions that actively engage patients(...)
Alira Health Further Expands its Digital Healthcare Platform with the Acquisition of Patchai
We acquired Patchai, a digital health technology company headquartered in Italy. Patchai offers intelligent digital health solutions that engage and empower patients in clinical research(...)
Alira Health Acquires BEPATIENT, A Step Forward in Humanizing Healthcare
We acquired BEPATIENT, a European healthcare technology company. BEPATIENT offers ‘real life’ digital patient data capture solutions for large pharmaceutical manufacturers, medical(...)
Alira Health Launches Series of Exclusive Barcelona Networking Events
We are launching series of exclusive Barcelona Life Sciences networking events! Join Barcelona Life Sciences community and gain valuable industry insights while meeting like-minded people.
Alira Health Announces it Role as Strategic Advisor to Montagu Private Equity
We are pleased to have advised Montagu PE in the acquisition of Intech, a target active in the design and manufacturing of complex reusable surgical instrumentation for Minimal Invasive(...)
Alira Health Welcomes Fredrik Nyberg as Partner and Regional Head
We are pleased to announce that Fredrik Nyberg has joined Alira Health as Partner and Regional Head
Alira Health Announces its Role as Strategic Advisor to Naxicap
Alira Health is proud to announce its role as strategic advisor to Naxicap in the equity investment in Ceres Pharma Bv.
Alira Health Expands Its Global Clinical and Data Capabilities Through the Acquisition of CROS NT
We have acquired CROS NT, a data-driven Contract Research Organization (CRO) headquartered in Italy with offices across Europe and the United States. CROS NT provides high quality,(...)
Latest from Alira Health
Event: Maximise the Effectiveness of Your CRO Partnership: Practical Guide
Event: Presentation of the 2021 BioRegion Report
We are thrilled to announce that Alira Health has contributed to the BioRegion Report 2021,
Webinar: Venture Summit Virtual Connect-Negotiating Term Sheets
Join David Uffer, Senior Partner and VP MedTech for an expert panel discussion on Negotiating Term Sheets.
Alira Health’s Transformation Talks: Navigating the Vaccines’ Renaissance
Tune into this episode of "Transformation Talks" to learn more about the the ups and downs of the vaccine industry, how the COVID pandemic has transformed it, and what is coming up next.
Alira Health’s Transformation Talks: Overcoming Challenges to Reimbursement in Robotic Surgery for the French Market
Our latest Alira Health Transformation Talks is all about Robotic Surgery.
Alira Health’s Transformation Talks: Creating a lifecycle of Patient Engagement
On the latest episode of Alira Health’s Transformation Talks Podcast, our guests Raj Kannan, CEO & President, Chiasma, Inc., Annabel de Maria, VP Patient Engagement at Alira Health,(...)
Your Favorite Alira Health Publications from 2021
As 2021 ends, take a look at Alira Health most popular publications about this year’s main healthcare trends.
An Insider Look at Vaccines: Yesterday, Today, Tomorrow
The COVID-19 pandemic has put vaccines in the spotlight. The pandemic has given the industry a considerable boost, and with lessons learned during the development and roll-out(...)
How—and Why—the Role of Clinical Data Manager is Changing
The relationship between Sponsor and CRO is a critical aspect of an effective and timely clinical trial; when the relationship is transparent and smooth, the benefit is seen by all parties.